13D Filing: OrbiMed Advisors and Adaptimmune Therapeutics PLC – ADR (ADAP)

Page 11 of 11

Page 11 of 11 – SEC Filing

EXHIBIT INDEX
Exhibit
Description
1.
Joint Filing Agreement among OrbiMed Advisors LLC and OrbiMed Capital GP V LLC.
2.
Investors’ Rights Agreement by and among the Issuer and each of the persons listed on Schedule A thereto, dated as of February 23, 2015 (incorporated by reference to Exhibit 4.5 to the Issuer’s Registration Statement on Form F-1 (SEC 333-203267), filed with the SEC on April 6, 2015).

Follow Adaptimmune Therapeutics Plc (NASDAQ:ADAP)

Page 11 of 11